Table 1 Baseline characteristics in obese morbid patients with type 2 diabetes (DMbaseline) and prediabetes (preDMbaseline)
DMbaseline (n = 48) | preDMbaseline (n = 57) | |
|---|---|---|
Weight (kg) | 131.8 (122.5, 145.5) | 126 (115, 141) |
BMI (kg/m2) | 53.5 (47.2, 57.1) | 49.6 (45.7, 54.2) |
Body fat (%) | 53.1 (46.9, 55.4) | 52.3 (47.2, 55) |
Waist (cm) | 137.5 (126.7, 150.2) | 133.5 (125.8, 145) |
Fasting plasma glucose (mg/dl) | 145 (110.5, 175.5) | 103 (96, 110) |
Plasma insulin (μU/ml) | 22 (15, 38) | 26.4 (18, 33.8) |
C-peptide (ng/ml) | 4.8 (3.8, 6.2) | 5 (3.8, 5.7) |
HOMA-IR | 8.5 (4.9, 14.3) | 6.7 (4.7, 8.8) |
HbA1c (%) | 7 (6.1, 8.3) | 5.5 (5.3, 5.9) |
Total Cholesterol (mg/dl) | 204 (176, 234.5) | 204 (186, 229) |
LDL-c (mg/dl) | 128.5 (100.8, 155.5) | 134 (113, 145) |
HDL-c (mg/dl) | 44 (36, 48) | 45 (38, 53) |
Triglycerides (mg/dl) | 164 (125, 238) | 133 (120, 172) |
SBP (mm Hg) | 140 (130, 155) | 136 (120, 152) |
DBP (mm Hg) | 90 (80, 96) | 83 (75.3, 96.5) |
Hypertension (%) | 44 (91.7%) | 42 (73.7%) |
Dyslipidemia (%) | 39 (81.3%) | 27 (47.4%) |
10-year CVD risk (FRS) (%) | 20 (12, 30) | 7 (3, 14) |